Endovascular treatment of acute pulmonary embolism
https://doi.org/10.18705/2311-4495-2018-5-4-5-11
Abstract
Thromboembolism of pulmonary artery is life-threatening condition due to acute right ventricle failure and cardiogenic shock. System thrombolysis is the main way of reperfusion in massive pulmonary embolism with a very high risk of fatal hemorrhage complications. There is a popular revascularization method in two last decades such as endovascular treatment. It allows to recover the blood flow into occluded pulmonary arteries up to three weeks after confirmed embolism episode and to decrease major bleeding risks. Now trials corroborate the high efficacy and safety of interventional treatment the usage of which would allow to improve prognosis in massive pulmonary embolism.
About the Authors
M. A. Chernyavskiy
Almazov National Medical Research Centre
Russian Federation
Competing Interests: No conflict of interest
Russian Federation
Mikhail A. Chernyavskiy - MD, PhD, head of researchdepartment of vascular and intervention surgery.
Akkuratova str. 2, Saint Petersburg, 197341
Competing Interests: No conflict of interest
Y. A. Kudaev
Almazov National Medical Research Centre
Russian Federation
Competing Interests: No conflict of interest
Russian Federation
Yuri A. Kudaev - MD, cardiologist of department of vascular and hybrid surgery.
Akkuratova str. 2, Saint Petersburg, 197341
Competing Interests: No conflict of interest
A. V. Chernov
Almazov National Medical Research Centre
Russian Federation
Competing Interests: No conflict of interest
Russian Federation
Artemiy V. Chernov - MD, head of department of vascular and hybrid surgery.
Akkuratova str. 2, Saint Petersburg, 197341
Competing Interests: No conflict of interest
N. N. Zherdev
Almazov National Medical Research Centre
Russian Federation
Competing Interests: No conflict of interest
Russian Federation
Nikolai N. Zherdev - MD, research assistant of researchdepartment of vascular and intervention surgery.
Akkuratova str. 2, Saint Petersburg, 197341
Competing Interests: No conflict of interest
D. V. Chernova
Almazov National Medical Research Centre
Russian Federation
Competing Interests: No conflict of interest
Russian Federation
Chernova Darya Victorovna - research assistant of research-department of vascular and intervention surgery and intervention surgery, MD jvascular and intervention surgery.
Akkuratova str. 2, Saint Petersburg, 197341
Competing Interests: No conflict of interest
References
1. Savelyev VS, Gologorgsky VA, Kirienko AI. Phlebology: Guideline for doctors. M.: Medicine, 2001. p. 175. In Russian.
2. Kucher N, Rossi E, De Rosa M, et al. Massive pulmonary embolism. Circulation. 2006; 113: 577–582.
3. Le Gal G, Righini M, Roy P, et al. Prediction of pulmonary embolism in the emergency department: The Revised Geneva Score. Ann Intern Med. 2006; 144: 165– 171.
4. Pengo V, Lensing AW, Prins MH, et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med. 2004; 350: 2257–2264.
5. Tapson VF, Humbert M. Incidence and prevalens of chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc. 2006; 3: 564–567.
6. Riedel M, Stanek V, Widimsky J, et al. Long-term follow-up of patients with pulmonary thromboembolism: late prognosis and evolusion of hemodynamic and respiratori data. Chest. 1982; 81: 151–158.
7. Konstantinides S, Torbicki A, Agnelli G, et al. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J. 2014; 35: 3033–3073.
8. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet. 1999; 353: 1386–1389.
9. Kasper W, Konstantinides S, Geibel A, et al. Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J Am Coll Cardiol. 1997; 30: 1165–1171.
10. Stein PD, Alnas M, Beemath A, et al. Outcome of pulmonary embolectomy. Am J Cardiol. 2007; 99: 421–423.
11. Fava M, Loyola S, Flores P, et al. Mechanical fragmentation and pharmacologic thrombolysis in massive pulmonary embolism. J Vasc Interv Radiol. 1997; 8(2): 261266.
12. Tajima H, Murata S, Kumazaki T, et al. Hybrid treatment of acute massive pulmonary thromboembolism: mechanical fragmentation with a modified rotating pigtail catheter, local fibrinolytic therapy, and clot aspiration followed by systemic fibrinolytic therapy. Interventional Radiology AJR. 2004; 183: 589-595.
13. Klevanets JE, Karpenko АA, Shilovа AN. Use of local thrombolysis in patients with massive pulmonary thromboembolism and moderate-to-severe pulmonary hypertension. Angiology and vascular surgery. 2017; 23(4): 7-11. In Russian.
14. Kuo WT, Banerjee A, Kim PS, et al. Pulmonary embolism response to fragmentation, embolectomy, and catheter thrombolysis (PERFECT): Initial results from a prospective multicenter registry. Chest. 2015; 148(3): 667673.
15. Piazza G, Hohlfelder B, Jaff MR, et al. A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism. JACC: Cardiovascular Interventions. 2015; 8(10): 1382-1392.
16. Kuo WT, Gould MK, Louie JD, et al. Catheterdirected therapy for the treatment of massive pulmonary embolism: systematic review and meta-analysis of modern techniques. J. Vasc. Interv. Radiol. 2009; 20: 1431–1440.
17. Jaff MR, McMurtry MS, Archer SL, et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation. 2011; 123: 1788 –1830.
18. Greenfield LJ, Bruce TA, Nichols NB. Transvenous pulmonary embolectomy by catheter device. Ann Surg. 1971; 174: 881–886.
19. Uflacker R, Strange C, Vujic I. Massive pulmonary embolism: preliminary results of treatment with the Amplatz thrombectomy device. J Vasc Interv Radiol. 1996; 7(4): 519–528.
20. Schmitz-Rode T, Janssens U, Duda SH, et al. Massive pulmonary embolism: percutaneous emergency treatment by pigtail rotation catheter. JACC. 2000; 36(2): 375-380.
21. Brady AJ, Crake T, Oakley CM. Percutaneous catheter fragmentation and distal dispersion of proximal pulmonary embolus. Lancet. 1991; 338: 1186–1189.
22. Engelberger RP, Kucher N. Catheter-based reperfusion treatment of pulmonary embolism. Circulation. 2011; 124: 2139–2144.
23. Skaf E, Beemath A, Siddiqui T, et al. Cathetertip embolectomy in the management of acute massive pulmonary embolism. Am J Cardiol. 2007; 99: 415–420.
24. Karpenko AA, Klevanets JE, Mironenko SP, et al. Functional state of right ventricular myocardium in patients with acute pulmonary embolism before and after thrombolytic therapy. Kardiologiia. 2014; 5: 29-33. In Russian.
25. Engelberger RP, Kucher N. Ultrasound-assisted thrombolysis for acute pulmonary embolism: a systematic review. Eur Heart J. 2014; 35(12): 758–764.
26. Kucher N, Boekstegers P, Muller O, et al. Randomized controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism. Circulation. 2014; 129(4): 479-486.
27. Biederer J, Charalambous N, Paulsen F, et al. Treatment of acute pulmonary embolism: local effects of three hydrodynamic thrombectomy devices in an ex vivo porcine model. J Endovasc Ther. 2006; 13: 549–560.
28. Danetz JS, McLafferty RB, Ayerdi J, et al. Pancreatitis caused by rheolytic thrombolysis: an unexpected complication. J Vasc Interv Radiol. 2004; 15: 857–860.
29. Dukkipati R, Yang EH, Adler S, et al. Acute kidney injury caused by intravascular hemolysis after mechanical thrombectomy. Nat Clin Pract Nephrol. 2009; 5: 112–116.
Review
For citations:
Chernyavskiy M.A., Kudaev Y.A., Chernov A.V., Zherdev N.N., Chernova D.V. Endovascular treatment of acute pulmonary embolism. Translational Medicine. 2018;5(4):5-11. (In Russ.) https://doi.org/10.18705/2311-4495-2018-5-4-5-11
Views:
1263
Email this article 